MacroGenics reported $1.55M in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
AbbVie USD 59M 13M Dec/2025
AstraZeneca USD 73M 62M Mar/2026
Biogen USD 37.9M 700K Mar/2026
Daiichi Sankyo JPY 9.96B 230M Mar/2024
Eli Lilly USD 65M 25M Sep/2025
Genmab DKK 25M 8M Jun/2025
Geron USD 4.04M 219K Dec/2025
Gilead Sciences USD 95M 7M Dec/2025
J&J USD 2.14 237M Mar/2026
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
MacroGenics USD 1.55M 26K Mar/2026
Merck USD 69M 27M Dec/2025
Pfizer USD 115M 51M Mar/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 193.3M 18.2M Dec/2025
Xencor USD 6.2M 338K Dec/2025